Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

GlaxoSmithKline’s Shingles Vaccine Gets Approval in Canada

Reuters Staff  |  

(Reuters)—Canadian health regulators have approved GlaxoSmithKline’s shingles vaccine, the company said on Friday.1

Shingrix, the British pharma company’s shingles vaccine for people aged 50 years or older, was unanimously recommended for approval by a U.S. Food and Drug Administration (FDA) advisory panel last week.

ADVERTISEMENT
SCROLL TO CONTINUE

Older people are most at risk of an outbreak of shingles, a painful, often debilitating blistering rash.

Shingles is the result of reactivation of the varicella zoster virus, which causes chickenpox and remains latent in those who have had that disease.

ADVERTISEMENT
SCROLL TO CONTINUE

Reference

  1. GlaxoSmithKline Plc. News release: GSK announces first approval of Shingrix in Canada. 2017 Oct 13.

Related Articles

    GSK Wins U.S. Shingles Vaccine Approval, U.K. Nod for Gene Therapy

    LONDON (Reuters)—GlaxoSmithKline has won U.S. approval for a new and improved shingles vaccine, the second of three key products for which the British drugmaker expects approval this year. It also secured a recommendation from U.K. cost authorities for a $700,000 gene therapy for so-called “bubble boy” disease—a step forward for the field of fixing faulty…

    The End of the Beginning: COVID-19 Vaccines & Other Conundrums

    “It’s like winning Powerball.” For months, there has been a steady trickle of questions from my patients, asking for my opinion about the new vaccines being developed to prevent COVID-19. More to the point, they want to know if they should be vaccinated. ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUEAfter some fits and starts, I finally struck…

    Space & Other Races

    On April 5, 1950, a small group of scientists met in Silver Spring, Md., to talk about geophysics. I know this is not the most riveting way to start, but if you stick with me, I promise the story will get much more interesting. ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUEThis group of scientists met to discuss…

    Shingles Vaccination Not at Goal Levels for U.S. Seniors

    (Reuters Health)—Just one in five people over age 60 in the U.S. have been vaccinated against a painful eruption of herpes zoster (shingles), despite recommendations that all of them should get the shot. It’s estimated that among people over age 50, one in three will eventually develop shingles. After age 80, half of adults have…